Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Cincinnati Financial Corporation (CINF) Price & Performance

AbCellera Biologics IncTrade
Cincinnati Financial CorporationTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Cincinnati Financial Corporation — how do they compare? AbCellera Biologics Inc trades at $9.11 (market cap $2.99B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.58B). The key difference: Cincinnati Financial Corporation is far larger — about 8.9× AbCellera Biologics Inc's market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLCINF
Market Cap
$2.99B$26.58B
Sector
HealthFinancials
52-Week High
$9.76$192.03
52-Week Low
$2.78$149.79
Enterprise Value
$2.58B$25.71B
Dividend Yield
2.17%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF